Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Clinical efficacy

Principal Investigator

Ulrich Keilholz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Charité, CBF

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

HaemaCBFMM03

NCT ID:

NCT00153569

Start Date:

March 2003

Completion Date:

September 2005

Related Keywords:

• Metastatic Melanoma
• Melanoma

Name	Location